Literature DB >> 26034073

GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administration.

Mikkel H Vendelbo1, Britt Christensen2, Solbritt B Grønbæk3, Morten Høgild3, Michael Madsen2, Steen B Pedersen3, Jens O L Jørgensen3, Niels Jessen2, Niels Møller3.   

Abstract

OBJECTIVE: Fasting and exercise stimulates, whereas glucose suppresses GH secretion, but it is uncertain how these conditions impact GH signaling in peripheral tissues. To test the original 'feast and famine hypothesis' by Rabinowitz and Zierler, according to which the metabolic effects of GH are predominant during fasting, we specifically hypothesized that fasting and exercise act in synergy to increase STAT-5b target gene expression. DESIGN AND METHODS: Eight healthy men were studied on two occasions in relation to a 1 h exercise bout: i) with a concomitant i.v. glucose infusion ('feast') and ii) after a 36 h fast ('famine'). Muscle and fat biopsy specimens were obtained before, immediately after, and 30 min after exercise.
RESULTS: GH increased during exercise on both examination days and this effect was amplified by fasting, and free fatty acid (FFA) levels increased after fasting. STAT-5b phosphorylation increased similarly following exercise on both occasions. In adipose tissue, suppressors of cytokine signaling 1 (SOCS1) and SOCS2 were increased after exercise on the fasting day and both fasting and exercise increased cytokine inducible SH2-containing protein (CISH). In muscle, SOCS2 and CISH mRNA were persistently increased after fasting. Muscle SOCS1, SOCS3, and CISH mRNA expression increased, whereas SOCS2 decreased after exercise on both examination days.
CONCLUSIONS: This study demonstrates that fasting and exercise act in tandem to amplify STAT-5b target gene expression (SOCS and CISH) in adipose and muscle tissue in accordance with the 'feast and famine hypothesis'; the adipose tissue signaling responses, which hitherto have not been scrutinized, may play a particular role in promoting FFA mobilization.
© 2015 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26034073     DOI: 10.1530/EJE-14-1157

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

1.  Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity.

Authors:  Jane E Yardley
Journal:  Diabetologia       Date:  2022-08-18       Impact factor: 10.460

2.  HORMONAL REGULATION OF CARBOHYDRATE AND FAT METABOLISM IN WOMEN WITH DIFFERENT OBESITY TYPES IN THE FOOD DEPRIVATION TEST.

Authors:  B B Pinkhasov; V G Selyatitskaya; D A Deev; O I Kuzminova; E L Astrakhantseva
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

3.  Targeted sequencing analysis of PPARG identifies a risk variant associated with obstructive sleep apnea in Chinese Han subjects.

Authors:  Xiaolu Jiao; Song Yang; Yunyun Yang; Juan Li; Haili Sun; Ming Zhang; Yunxiao Yang; Yanwen Qin
Journal:  Sleep Breath       Date:  2019-05-02       Impact factor: 2.816

4.  Skeletal Muscle Transcriptomic Comparison Between Men and Women in Response to Acute Sprint Exercise.

Authors:  Mingkun Nie; Qingling Liu; Cheng Yan
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

5.  The acromegaly lipodystrophy.

Authors:  Pamela U Freda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

6.  Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: A randomized controlled crossover trial.

Authors:  Astrid Johannesson Hjelholt; Kevin Y Lee; Mai Christiansen Arlien-Søborg; Steen Bønløkke Pedersen; John J Kopchick; Vishwajeet Puri; Niels Jessen; Jens Otto L Jørgensen
Journal:  Mol Metab       Date:  2019-08-20       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.